Skip to main content

ResMed| ratios

  • RMD · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$239.53+0.27%Close 13 Nov 2026 · Market value $33.91B

In fiscal 2026 (the year to 30 Jun 2026), ResMed| had an operating margin of 33.4%, a return on equity of 24.3%, a return on invested capital of 23.6%.

From ResMed|'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 30 Jun 2026.

Annual

ResMed| ratios, annual
USDFY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Gross margin60.1%60.0%59.6%60.0%62.1%63.7%60.2%58.0%58.1%57.0%57.3%58.1%57.5%56.6%55.8%56.7%59.4%61.1%
Operating margin20.7%22.0%21.5%21.5%23.4%26.1%24.4%23.3%20.6%23.2%22.2%27.4%28.3%28.0%26.8%28.2%32.7%33.4%
Net margin15.9%17.4%18.3%18.6%20.3%22.2%21.0%19.2%16.6%13.5%15.5%21.0%14.8%21.8%21.3%21.8%27.2%26.9%
Free cash flow margin14.0%12.0%17.4%24.6%22.4%20.5%19.1%26.6%17.0%18.9%15.0%23.9%19.8%6.0%13.6%27.8%32.3%29.2%
Return on equity13.1%15.8%15.0%15.3%19.1%20.5%21.1%21.5%18.7%15.7%19.6%27.2%17.6%25.0%24.0%22.7%25.9%24.3%
Return on assets—10.8%10.8%10.7%13.0%14.2%14.6%12.6%10.4%10.0%12.6%15.8%10.4%16.5%15.6%15.6%18.7%17.5%
Return on capital employed—18.3%16.8%15.7%20.2%21.7%20.4%18.9%14.9%19.1%19.0%21.5%23.2%24.3%21.8%22.1%25.7%25.6%
Return on invested capital—18.0%18.6%19.8%25.5%27.8%26.9%19.8%15.2%13.7%15.2%19.2%13.3%20.4%18.1%18.0%23.3%23.6%
Current ratio—3.156.195.382.525.775.282.234.572.082.062.531.732.803.122.593.443.10
Debt to equity—0.090.060.160.190.170.190.690.550.140.610.520.280.270.380.180.140.13
Net debt / EBITDA—−1.22−1.88−1.47−1.33−1.26−0.860.860.480.141.540.870.470.561.040.42−0.19−0.31
Interest coverage—90.13151.8361.5155.5566.0970.8338.2815.0819.1116.0220.0537.67—————
Cash conversion88.2%69.1%95.4%132%110%92.3%90.9%139%103%140%96.5%114%134%27.8%63.9%128%119%108%
Dividend payout————31.6%41.0%44.6%47.7%54.4%63.2%52.3%36.2%47.8%31.5%28.8%27.7%22.2%23.0%
SBC / Revenue2.8%2.7%2.5%2.2%2.5%2.8%2.9%2.5%2.2%2.1%2.0%1.9%2.0%1.8%1.7%1.7%1.8%1.8%

Quarterly

ResMed| ratios, quarterly
USDQ2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Gross margin55.6%57.9%58.5%58.6%58.6%59.3%60.8%61.2%61.8%62.2%58.8%61.5%
Operating margin23.7%31.3%31.2%31.6%32.5%33.0%33.7%33.4%34.6%34.9%30.7%32.0%
Net margin18.0%25.1%23.9%25.4%26.9%28.3%28.2%26.1%27.6%27.9%26.2%29.6%
Free cash flow margin21.5%31.8%33.9%25.1%22.5%43.2%37.7%31.0%21.9%36.4%27.6%26.4%
Return on equity4.7%6.5%6.0%6.0%6.6%6.6%6.4%5.7%6.2%6.1%5.8%7.0%
Return on assets3.2%4.4%4.5%4.4%4.8%4.9%4.6%4.2%4.6%4.5%4.0%4.3%
Return on capital employed4.5%6.2%6.4%6.1%6.6%6.4%6.4%6.3%6.8%6.7%5.9%6.6%
Return on invested capital3.6%5.0%5.3%5.2%5.8%6.3%6.1%5.7%6.2%6.4%5.5%5.6%
Current ratio3.113.042.592.923.333.413.442.893.063.013.102.65
Debt to equity0.310.250.180.160.160.150.140.140.130.130.130.10
Net debt / EBITDA3.692.221.500.980.69−0.20−0.69−1.09−1.05−1.46−1.30−0.81
Interest coverage———————62.71———94.10
Cash conversion119%127%142%98.8%83.6%153%134%119%79.3%131%105%89.3%
Dividend payout33.8%23.5%24.1%25.0%22.5%21.3%20.4%25.2%22.3%21.9%22.7%22.7%
SBC / Revenue1.7%1.7%1.7%1.6%1.8%1.9%1.8%1.6%2.0%1.9%1.9%2.1%

The main figures as JSON and plain text. See data and methodology.

RMD in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.